Why the study?
Does screening for silent myocardial ischemia reduce cardiovascular complications and mortality in asymptomatic diabetic patients with high cardiovascular risk?
Does screening for silent myocardial ischemia reduce cardiovascular complications and mortality in asymptomatic diabetic patients with high cardiovascular risk?
Current guidelines recommend screening for silent myocardial ischemia in high-risk asymptomatic diabetic patients, though the benefit of systematic screening requires further evaluation in randomized trials.
No takes yet. Share an insight, caveat, or question.
Guidelines endorse targeted screening in high-risk asymptomatic diabetics; leaves open outcome benefit, requiring RCTs before routine adoption.
Barthélémy et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: